Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
350 participants
OBSERVATIONAL
2007-10-31
2009-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this two-part study is to identify and clinically confirm the presence of vulvodynia in women diagnosed with Interstitial Cystitis (IC).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Relationship: Interstitial Cystitis & Vulvodynia-Part 2
NCT00751010
Assessing Chronic Pain Conditions in Patients (Pts) With and Without (w&wo) Interstitial Cystitis
NCT01138800
Study of Biomarkers and the Relaxation Response Using Guided Imagery in Women With IC
NCT00420550
Acupuncture for Vulvodynia: A Pre-pilot Study
NCT02704234
Women's Health Study: Immunological Factors and Risk of Vulvodynia
NCT02404961
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Survey
Patients with interstitial cystitis
Physical Examination
Patients will be invited to be evaluated in the Urology Research office at a future date.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physical Examination
Patients will be invited to be evaluated in the Urology Research office at a future date.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of interstitial cystitis
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
William Beaumont Hospitals
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Donna Carrico, NP
Role: PRINCIPAL_INVESTIGATOR
William Beaumont Hospitals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
William Beaumont Hospital
Royal Oak, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2007-183
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.